| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/15/2004 | CN1166690C Hepatitis C inhibitor peptides |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166406C Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 09/15/2004 | CN1166399C Medicine spray for treating throat disease and stomatopathy |
| 09/15/2004 | CN1166398C Medicine for treating intestinal disease |
| 09/15/2004 | CN1166385C Chinese herbal medicine composition for treating caries pain and its prepn |
| 09/15/2004 | CN1166376C Powder medicine for treating hepatitis A and B |
| 09/15/2004 | CN1166373C Powdered Chinese medicine for treating diarrhea |
| 09/15/2004 | CN1166371C Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/15/2004 | CN1166359C New oral dosage form of Anethol Trithione |
| 09/14/2004 | US6790960 Compounds |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 09/14/2004 | US6790447 Peptides for treatment of autoimmune diseases |
| 09/14/2004 | US6790446 Campylobacter vaccine |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/10/2004 | WO2004077367A1 Tetracyclic sulfenamide compound |
| 09/10/2004 | WO2004076487A1 Antibody and use thereof |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
| 09/10/2004 | WO2004076440A1 Polymorphs of s-omeprazole |
| 09/10/2004 | WO2004076415A1 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents |
| 09/10/2004 | WO2004075917A1 Organ or tissue fibrosis inhibitor |
| 09/10/2004 | WO2004075906A1 Antiinflammtory agent and antiinflammatory medical material |
| 09/10/2004 | WO2004075846A2 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/10/2004 | WO2004060263A3 Magnesium salt of imidazole derivative |
| 09/10/2004 | WO2004054565A8 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2517714A1 Polymorphs of s-omeprazole |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176446 Substituted amino dicarboxylic acid derivatives |
| 09/09/2004 | US20040176438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176406 Pyrido [2,1-a] isoquinoline derivatives |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176320 Use of at least one glycoinhibitor substance |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175418 Teste masking pharmaceutical composition |
| 09/09/2004 | US20040175372 Inhibits rotavirus infection and other pathogenic microorganisms; viricides; preventing and treating diarrhea of mammals, livestock, and poultry |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/08/2004 | EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them. |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
| 09/08/2004 | EP1454634A1 Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same |
| 09/08/2004 | EP1454533A1 Stimulation of saliva generation |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453840A1 Phosphonates useful as modulators of t-gamma-9-delta-2 lymphocyte activity |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 09/08/2004 | EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist |
| 09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |